As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are ...

Gilead Sciences agreed to pay $202 million to the U.S. government and various states to settle claims it used speaker ...

President Trump has eliminated funding for programs aimed at ending the growing HIV epidemic among minority communities, ...

Over the years, a host of large drugmakers have inked settlements with the federal authorities to resolve allegations that ...

The company paid to settle allegations of paying kickbacks to doctors in exchange for prescribing several of its HIV ...

Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying ...

Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

Gilead gave the money to doctors who spoke at HIV Speaker Program events in the form of honoraria payments, meals and travel expenses, according to the U.S. Attorney's Office in Manhattan ...